Amphetamine derivatives as Monoamine Oxidase Inhibitors
Author
dc.contributor.author
Reyes Parada, Miguel
Author
dc.contributor.author
Iturriaga Vásquez, Patricio
Author
dc.contributor.author
Cassels Niven, Bruce
Admission date
dc.date.accessioned
2020-05-13T22:01:13Z
Available date
dc.date.available
2020-05-13T22:01:13Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Front Pharmacol. 2020; 10: 1590
es_ES
Identifier
dc.identifier.other
10.3389/fphar.2019.01590
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/174697
Abstract
dc.description.abstract
Amphetamine and its derivatives exhibit a wide range of pharmacological activities, including psychostimulant, hallucinogenic, entactogenic, anorectic, or antidepressant effects. The mechanisms of action underlying these effects are usually related to the ability of the different amphetamines to interact with diverse monoamine transporters or receptors. Moreover, many of these compounds are also potent and selective monoamine oxidase inhibitors. In the present work, we review how structural modifications on the aromatic ring, the amino group and/or the aliphatic side chain of the parent scaffold, modulate the enzyme inhibitory properties of hundreds of amphetamine derivatives. Furthermore, we discuss how monoamine oxidase inhibition might influence the pharmacology of these compounds.
es_ES
Patrocinador
dc.description.sponsorship
Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) CONICYT FONDECYT 1170662 1150615 1150868